Of note, we found that ERCC2 alterations (which are recurrently found in bladder cancer) co-occur significantly with POLD2 expression (P = 0.010; data not shown), but not with CAD expression, suggesting POLD2 as putative gene of interest in future studies examining ERCC2. Here, POLD2 is linked to urinary bladder carcinoma.